AMENDMENT TO SERIES D PREFERRED STOCK SUBSCRIPTION AGREEMENTSeries D Preferred Stock Subscription Agreement • October 14th, 2011 • ChemoCentryx, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 14th, 2011 Company IndustryThis Amendment (the “Amendment”) to Series D Preferred Stock Subscription Agreement (the “Agreement”) dated as of November 8, 2007 is entered into by and between ChemoCentryx, Inc., a Delaware corporation (the “Company”) and Glaxo Group Limited, a limited liability company organized under the laws of England doing business as GlaxoSmithKline (“GSK”).